Gutierrez Andres H, Terry Frances E, Rosenberg Amy S, Martin William D, De Groot Anne S
EpiVax, Inc., Providence, RI, United States.
Front Immunol. 2025 Apr 17;16:1535826. doi: 10.3389/fimmu.2025.1535826. eCollection 2025.
Antibody maturation in the lymphoid follicle produces antibodies with improved binding affinity. This process requires iterative rounds of mutation and B cell expansion, supported by T cells that recognize epitopes presented on the B cell's MHC-II. In this comprehensive antibody repertoire analysis, we find that established regulatory T cell epitopes (Tregitopes) decline in maturing antibody sequences as somatic hypermutation (SHM) increases, but potential T effector epitopes do not decline. A previous analysis of B cell receptor (BCR)-derived HLA-DR epitopes present in memory antibody repertoires from seven healthy human donors revealed a decrease in donor-specific epitope content with SHM. Moreover, T cell epitope depletion was associated with class-switching and long-term secretion of antibody into serum. Significant depletion of high-affinity germline-encoded epitopes in high SHM sequences was also observed, but the predicted phenotype of T cells responding to the BCR-derived epitopes (regulatory vs. effector) was not previously evaluated.
In this follow-on study, we screened a different set of four donor repertoires to investigate the dynamics of donor-specific HLA-DR T cell epitopes and three subsets of T cell epitope content: previously validated T cell epitopes recognized by thymus-derived Tregs (Tregitopes), potentially tolerated T cell epitopes, and potential effector T cell epitopes.
Our results show that Tregitope content reduction is correlated with SHM, suggesting that Tregitopes are removed during maturation. Moreover, T cell epitopes that are likely to be tolerated or tolerogenic were also removed with SHM progression. In contrast, potential T effector epitope content increased with SHM. Tregitope depletion occurred in multiple V-gene pair combinations and was the most frequent T cell epitope change. Furthermore, Tregitope content in IgA and IgG sequences was lower and had greater negative correlation with SHM than IgM, indicating that Tregitope removal is likely associated with class-switching. Tregitope depletion was also associated with maturation to plasmablasts. In vitro, representative Tregitopes inhibited CD4+ T cell proliferation. Mutations introduced by SHM altered Tregitope HLA-DR binding affinities.
The correlation of Tregitope depletion with increasing SHM implies that the activity of thymus-derived Treg cells in immune responses to antibodies is diminished with SHM, maturation, and isotype switching, supporting the generation of anti-idiotype responses.
淋巴滤泡中的抗体成熟过程会产生结合亲和力更高的抗体。这一过程需要经过多轮的突变和B细胞扩增,并由识别B细胞MHC-II上呈递表位的T细胞提供支持。在这项全面的抗体库分析中,我们发现随着体细胞高频突变(SHM)增加,成熟抗体序列中已确定的调节性T细胞表位(Tregitopes)减少,但潜在的T效应细胞表位并未减少。先前对来自7名健康人类供体的记忆抗体库中B细胞受体(BCR)衍生的HLA-DR表位进行的分析显示,随着SHM的增加,供体特异性表位含量减少。此外,T细胞表位的耗竭与类别转换以及抗体长期分泌到血清中有关。在高SHM序列中也观察到高亲和力种系编码表位的显著耗竭,但先前未评估对BCR衍生表位作出反应的T细胞的预测表型(调节性与效应性)。
在这项后续研究中,我们筛选了另一组4个供体的抗体库,以研究供体特异性HLA-DR T细胞表位的动态变化以及T细胞表位含量的三个子集:先前经胸腺来源的调节性T细胞(Tregitopes)识别的已验证T细胞表位、可能耐受的T细胞表位和潜在的效应性T细胞表位。
我们的结果表明,Tregitope含量的降低与SHM相关,这表明Tregitopes在成熟过程中被去除。此外,随着SHM的进展,可能被耐受或具有耐受性的T细胞表位也被去除。相比之下,潜在的T效应细胞表位含量随着SHM的增加而增加。Tregitope耗竭发生在多种V基因对组合中,并且是最常见的T细胞表位变化。此外,IgA和IgG序列中的Tregitope含量低于IgM,并且与SHM的负相关性更强,这表明Tregitope的去除可能与类别转换有关。Tregitope耗竭也与向浆母细胞的成熟有关。在体外,代表性的Tregitopes抑制CD4+ T细胞增殖。SHM引入的突变改变了Tregitope与HLA-DR的结合亲和力。
Tregitope耗竭与SHM增加之间的相关性意味着,在针对抗体的免疫反应中,胸腺来源的调节性T细胞的活性随着SHM、成熟和同种型转换而减弱,这支持了抗独特型反应的产生。